rs761492600

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001018113.3(FANCB):​c.2327C>T​(p.Ala776Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000257 in 1,208,221 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A776A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000026 ( 0 hom. 11 hem. )

Consequence

FANCB
NM_001018113.3 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 1.39

Publications

0 publications found
Variant links:
Genes affected
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]
FANCB Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group B
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • VACTERL association, X-linked, with or without hydrocephalus
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • VACTERL with hydrocephalus
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.055894375).
BP6
Variant X-14843820-G-A is Benign according to our data. Variant chrX-14843820-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 456183.
BS2
High Hemizygotes in GnomAdExome4 at 11 AR,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCBNM_001018113.3 linkc.2327C>T p.Ala776Val missense_variant Exon 10 of 10 ENST00000650831.1 NP_001018123.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCBENST00000650831.1 linkc.2327C>T p.Ala776Val missense_variant Exon 10 of 10 NM_001018113.3 ENSP00000498215.1

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111426
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000377
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000109
AC:
2
AN:
182897
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000245
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000264
AC:
29
AN:
1096795
Hom.:
0
Cov.:
29
AF XY:
0.0000304
AC XY:
11
AN XY:
362211
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26378
American (AMR)
AF:
0.00
AC:
0
AN:
35201
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54104
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40342
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4131
European-Non Finnish (NFE)
AF:
0.0000333
AC:
28
AN:
841016
Other (OTH)
AF:
0.00
AC:
0
AN:
46057
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111426
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33618
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30646
American (AMR)
AF:
0.00
AC:
0
AN:
10434
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3548
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2674
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5977
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000377
AC:
2
AN:
53084
Other (OTH)
AF:
0.00
AC:
0
AN:
1496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Fanconi anemia Benign:2
Oct 23, 2020
Sema4, Sema4
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Apr 28, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Fanconi anemia complementation group B Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

VACTERL association, X-linked, with or without hydrocephalus Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.15
T;T;T
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.56
T;.;T
M_CAP
Benign
0.052
D
MetaRNN
Benign
0.056
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
2.0
M;M;.
PhyloP100
1.4
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.058
Sift
Benign
0.036
D;D;D
Sift4G
Benign
0.10
T;T;T
Polyphen
0.51
P;P;.
Vest4
0.057
MutPred
0.18
Gain of catalytic residue at A776 (P = 0.0179);Gain of catalytic residue at A776 (P = 0.0179);Gain of catalytic residue at A776 (P = 0.0179);
MVP
0.27
MPC
0.12
ClinPred
0.13
T
GERP RS
4.7
Varity_R
0.13
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761492600; hg19: chrX-14861942; API